The chart below shows typical result timelines for different goals
GLP-1 (Glucagon-Like Peptide-1) receptor agonists are medications that mimic the body's natural GLP-1 hormone
doi: 10.1111/nmo.13697 86 RotondoAJanssenPMulFTackJ
Are lifestyle therapies effective for NAFLD treatment
At the same time, it triggers vasoconstriction to blood vessels serving less essential organs such as the gastrointestinal tract, kidneys, and skin, and downregulates some components of the immune system
Safety Takeaway: While the evidence from controlled human trials suggests a manageable adverse event profile, the products full extent of long-term safety, especially regarding chronic and rare side effects, remains undetermined until the completion of ongoing large-scale clinical programs and subsequent regulatory review and approval